Treatment as Prevention¨

Icelandic HCV elimination program treats majority of viremic population

Since its launch in 2016, a hepatitis C elimination program in Iceland has treated approximately 56% to 70% of the estimated viremic population with direct-acting antivirals, according to a recently published update. “The idea was to offer DAAs to all HCV-positive patients within an entire population within a relatively short time frame and simultaneously initiate

Icelandic HCV elimination program treats majority of viremic population Read More »

A shift over time in the HIV ward of one of Canada’s largest hospitals

Numerous studies have found that the use of potent combination anti-HIV therapy (ART) strengthens the immune system and overall health. ART does this by gradually reducing the amount of HIV produced to very low levels-commonly called “undetectable.” This then allows the immune system to partially repair itself. The benefit of ART is so profound that

A shift over time in the HIV ward of one of Canada’s largest hospitals Read More »

Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight

People with HIV over the age of 50 are more likely to have developed type 2 diabetes if they started antiretroviral treatment before 1999 or had a longer exposure to older antiretroviral drugs such as stavudine (d4T) or first-generation protease inhibitors such as nelfinavir or indinavir, according to a study of people receiving HIV care

Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight Read More »

‘We’ve been waiting for this for a long time’: B.C. to fund HIV-prevention drug

Daily prevention pill was available previously but it was not covered, and high prices made it inaccessible People at high risk of becoming infected with the HIV virus will soon be able to access free medication to protect against it in B.C. Starting on Jan. 1, the province of British Columbia will cover the costs

‘We’ve been waiting for this for a long time’: B.C. to fund HIV-prevention drug Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below